Scarica l'app Stockscreener
6.08
13.02%
-0.91
Dopo l'orario di chiusura:
6.05
-0.03
-0.49%
Precedente Chiudi:
$6.99
Aprire:
$6.8
Volume 24 ore:
85,648
Relative Volume:
1.43
Capitalizzazione di mercato:
$227.56M
Reddito:
$4.71M
Utile/perdita netta:
$-46.77M
Rapporto P/E:
-3.6208
EPS:
-1.6792
Flusso di cassa netto:
$-60.34M
1 W Prestazione:
-20.52%
1M Prestazione:
-38.59%
6M Prestazione:
-33.11%
1 anno Prestazione:
-50.25%
Intervallo 1D:
$5.76
$6.80
Intervallo di 1 settimana:
$5.76
$7.51
Portata 52W:
$5.76
$12.79
Nyxoah Sa Stock (NYXH) Company Profile
Nome
Nyxoah Sa
Settore
Industria
Telefono
-
Indirizzo
-
Confronta NYXH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NYXH
Nyxoah Sa
|
6.08 | 227.56M | 4.71M | -46.77M | -60.34M | -1.6792 |
|
ISRG
Intuitive Surgical Inc
|
451.58 | 161.79B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
207.34 | 66.11B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
83.82 | 41.46B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
205.17 | 30.13B | 4.93B | 1.25B | 1.38B | 8.47 |
|
BAX
Baxter International Inc
|
28.79 | 14.77B | 17.28B | 108.00M | 391.00M | 0.20 |
Nyxoah Sa Stock (NYXH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-07-31 | Iniziato | H.C. Wainwright | Buy |
| 2023-07-19 | Iniziato | Robert W. Baird | Neutral |
| 2022-04-21 | Iniziato | Oppenheimer | Outperform |
| 2022-04-06 | Iniziato | Wolfe Research | Peer Perform |
| 2021-12-21 | Ripresa | Cantor Fitzgerald | Overweight |
| 2021-07-28 | Iniziato | Cantor Fitzgerald | Overweight |
Mostra tutto
Nyxoah Sa Borsa (NYXH) Ultime notizie
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - GlobeNewswire Inc.
Nyxoah S.A. Investors: Company Investigated by the Portnoy Law Firm - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A.NYXH - PR Newswire
Oppenheimer maintains $13 target on Nyxoah shares post-FDA talks - Investing.com India
Nyxoah S.A. Investors: Company Investigated By The Portnoy Law Firm - menafn
HC Wainwright Comments on Nyxoah’s Q1 Earnings (NASDAQ:NYXH) - Defense World
Nyxoah S.A. Being Investigated on Behalf of Nyxoah S.A. Investors. Contact Levi & Korsinsky For Details - ACCESS Newswire
HC Wainwright Lowers Nyxoah (NASDAQ:NYXH) Price Target to $15.00 - Defense World
Nyxoah SA: A Medical Technology Company with a Big Loss - RagingBull
Nyxoah announces FDA approvable letter for Genio pre-market approval application - TipRanks
Nyxoah Says FDA Issues Approvable Letter for Genio System - MarketScreener
FDA Issues Approvable Letter For Nyxoah's Genio® System - TradingView
FDA Clears Path Forward for Nyxoah's Revolutionary Sleep Apnea Treatment - Stock Titan
Stifel Nicolaus Has Lowered Expectations for Nyxoah (NASDAQ:NYXH) Stock Price - Defense World
Stifel cuts Nyxoah stock price target to $15, maintains Buy By Investing.com - Investing.com Canada
Nyxoah SA (NYXH) Reports Q4 Loss, Lags Revenue Estimates - MSN
(NYXH) Investment Analysis - Stock Traders Daily
Stifel cuts Nyxoah stock price target to $15, maintains Buy - Investing.com
Nyxoah S.A. (NASDAQ:NYXH) Q4 2024 Earnings Call Transcript - Insider Monkey
H.C. Wainwright maintains Buy on Nyxoah shares, $17 target - Investing.com
Nyxoah SA (NYXH) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic US ... By GuruFocus - Investing.com Canada
Nyxoah Reports 2024 Financial Results and U.S. Launch Plans - TipRanks
Nyxoah Sa’s Earnings Call: Efficacy and Expansion - TipRanks
Nyxoah Reports Strong Q4 Growth as Sleep Apnea Device Nears FDA Green Light - Stock Titan
Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating Results - The Manila Times
Nyxoah to Release Fourth Quarter and Financial Year 2024 Financial Results on March 13, 2025 - The Manila Times
Critical Survey: Nyxoah (NASDAQ:NYXH) vs. PolyPid (NASDAQ:PYPD) - Defense World
Nyxoah (NYXH) to Release Quarterly Earnings on Thursday - Defense World
Transparency Notification: Vestal Point Capital’s Stake in Nyxoah - PanAsiaBiz
(NYXH) Investment Report - news.stocktradersdaily.com
Nyxoah to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference - The Manila Times
Sleep Apnea Innovator Nyxoah Takes Center Stage at Major Healthcare Conference - StockTitan
Nyxoah (NYXH) to Release Quarterly Earnings on Tuesday - Defense World
Nyxoah (NYXH) Projected to Post Earnings on Tuesday - MarketBeat
Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) versus Nyxoah (NASDAQ:NYXH) Critical Review - Defense World
(NYXH) On The My Stocks Page - Stock Traders Daily
Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle East - GlobeNewswire
Revolutionary Sleep Apnea Treatment Crosses Borders: Inside Genio's Middle East Launch - StockTitan
Nyxoah Launches Genio Therapy in Middle East with First UAE Implantation - TipRanks
Nyxoah (NASDAQ:NYXH) Stock Price Up 0.6%Here's What Happened - MarketBeat
Tri Pointe Homes (TPH) To Report Earnings Tomorrow: Here Is What To Expect - The Globe and Mail
Nyxoah (NASDAQ:NYXH) Shares Up 0.6% – Here’s What Happened - Defense World
Nyxoah to Present at BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference - Environmental Expert
(NYXH) Trading Report - Stock Traders Daily
Trend Tracker for (NYXH) - Stock Traders Daily
Cantor Fitzgerald Predicts Nyxoah FY2025 Earnings - Defense World
NYXHNyxoah SA Ordinary Shares Latest Stock News & Market Updates - StockTitan
Nyxoah Receives Transparency Notification from BlackRock - TipRanks
Nyxoah Sa Azioni (NYXH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):